메뉴 건너뛰기




Volumn 14, Issue 6, 2012, Pages

Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: Results from IBCSG Trials VIII and IX

(13)  Coates, Alan S a,b,c   Millar, Ewan K A a,d,e,f   O'Toole, Sandra A a,f,g,h   Molloy, Timothy J a   Viale, Giuseppe c,i,j   Goldhirsch, Aron c,i   Regan, Meredith M c,k   Gelber, Richard D c,k   Sun, Zhuoxin c,k   Castiglione Gertsch, Monica c   Gusterson, Barry c   Musgrove, Elizabeth A a,f   Sutherland, Robert L a,c,f  


Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; ESTROGEN RECEPTOR; FLUOROURACIL; GOSERELIN; METHOTREXATE; PROTEIN P53; TAMOXIFEN; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; TUMOR MARKER;

EID: 84868259237     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3348     Document Type: Article
Times cited : (53)

References (53)
  • 1
    • 70349443284 scopus 로고    scopus 로고
    • When mutants gain new powers: news from the mutant p53 field
    • Brosh R, Rotter V. When mutants gain new powers: news from the mutant p53 field. Nat Rev Cancer 2009, 9:701-713.
    • (2009) Nat Rev Cancer , vol.9 , pp. 701-713
    • Brosh, R.1    Rotter, V.2
  • 2
    • 34047207337 scopus 로고    scopus 로고
    • TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes
    • 10.1038/sj.onc.1210302, 17401424
    • Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P, Olivier M. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene 2007, 26:2157-2165. 10.1038/sj.onc.1210302, 17401424.
    • (2007) Oncogene , vol.26 , pp. 2157-2165
    • Petitjean, A.1    Achatz, M.I.2    Borresen-Dale, A.L.3    Hainaut, P.4    Olivier, M.5
  • 4
    • 36849069347 scopus 로고    scopus 로고
    • American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer
    • 10.1200/JCO.2007.14.2364, 17954709
    • Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, Somerfield MR, Hayes DF, Bast RC. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 2007, 25:5287-5312. 10.1200/JCO.2007.14.2364, 17954709.
    • (2007) J Clin Oncol , vol.25 , pp. 5287-5312
    • Harris, L.1    Fritsche, H.2    Mennel, R.3    Norton, L.4    Ravdin, P.5    Taube, S.6    Somerfield, M.R.7    Hayes, D.F.8    Bast, R.C.9
  • 5
    • 0037221767 scopus 로고    scopus 로고
    • TP53 and breast cancer
    • 10.1002/humu.10174, 12619115
    • Borresen-Dale AL. TP53 and breast cancer. Hum Mutat 2003, 21:292-300. 10.1002/humu.10174, 12619115.
    • (2003) Hum Mutat , vol.21 , pp. 292-300
    • Borresen-Dale, A.L.1
  • 11
    • 0031022938 scopus 로고    scopus 로고
    • Field cancerisation and polyclonal p53 mutation in the upper aero-digestive tract
    • 10.1038/sj.onc.1200812, 9010218
    • Waridel F, Estreicher A, Bron L, Flaman JM, Fontolliet C, Monnier P, Frebourg T, Iggo R. Field cancerisation and polyclonal p53 mutation in the upper aero-digestive tract. Oncogene 1997, 14:163-169. 10.1038/sj.onc.1200812, 9010218.
    • (1997) Oncogene , vol.14 , pp. 163-169
    • Waridel, F.1    Estreicher, A.2    Bron, L.3    Flaman, J.M.4    Fontolliet, C.5    Monnier, P.6    Frebourg, T.7    Iggo, R.8
  • 13
    • 26444546442 scopus 로고    scopus 로고
    • An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival
    • 10.1073/pnas.0506230102, 1197273, 16141321
    • Miller LD, Smeds J, George J, Vega VB, Vergara L, Ploner A, Pawitan Y, Hall P, Klaar S, Liu ET, Bergh J. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci USA 2005, 102:13550-13555. 10.1073/pnas.0506230102, 1197273, 16141321.
    • (2005) Proc Natl Acad Sci USA , vol.102 , pp. 13550-13555
    • Miller, L.D.1    Smeds, J.2    George, J.3    Vega, V.B.4    Vergara, L.5    Ploner, A.6    Pawitan, Y.7    Hall, P.8    Klaar, S.9    Liu, E.T.10    Bergh, J.11
  • 14
  • 15
    • 0035225608 scopus 로고    scopus 로고
    • Prognostic value of p53 protein expression in breast cancer; an immunohistochemical analysis of frozen sections in 514 Japanese women
    • 10.1007/BF02967508, 11668240
    • Tsutsui S, Ohno S, Murakam S, Hachitanda Y, Oda S. Prognostic value of p53 protein expression in breast cancer; an immunohistochemical analysis of frozen sections in 514 Japanese women. Breast Cancer 2001, 8:194-201. 10.1007/BF02967508, 11668240.
    • (2001) Breast Cancer , vol.8 , pp. 194-201
    • Tsutsui, S.1    Ohno, S.2    Murakam, S.3    Hachitanda, Y.4    Oda, S.5
  • 16
    • 0028173703 scopus 로고
    • P53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment
    • 10.1002/1097-0142(19940415)73:8<2147::AID-CNCR2820730820>3.0.CO;2-5, 8156519
    • Caleffi M, Teague MW, Jensen RA, Vnencak-Jones CL, Dupont WD, Parl FF. p53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment. Cancer 1994, 73:2147-2156. 10.1002/1097-0142(19940415)73:8<2147::AID-CNCR2820730820>3.0.CO;2-5, 8156519.
    • (1994) Cancer , vol.73 , pp. 2147-2156
    • Caleffi, M.1    Teague, M.W.2    Jensen, R.A.3    Vnencak-Jones, C.L.4    Dupont, W.D.5    Parl, F.F.6
  • 20
    • 78651100119 scopus 로고    scopus 로고
    • Inactivation of p53 in breast cancers correlates with stem cell transcriptional signatures
    • 10.1073/pnas.1017001108, 3012457, 21149740
    • Mizuno H, Spike BT, Wahl GM, Levine AJ. Inactivation of p53 in breast cancers correlates with stem cell transcriptional signatures. Proc Natl Acad Sci USA 2010, 107:22745-22750. 10.1073/pnas.1017001108, 3012457, 21149740.
    • (2010) Proc Natl Acad Sci USA , vol.107 , pp. 22745-22750
    • Mizuno, H.1    Spike, B.T.2    Wahl, G.M.3    Levine, A.J.4
  • 21
    • 0027394794 scopus 로고
    • Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer
    • 10.1093/jnci/85.3.200, 8423624
    • Allred DC, Clark GM, Elledge R, Fuqua SA, Brown RW, Chamness GC, Osborne CK, McGuire WL. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 1993, 85:200-206. 10.1093/jnci/85.3.200, 8423624.
    • (1993) J Natl Cancer Inst , vol.85 , pp. 200-206
    • Allred, D.C.1    Clark, G.M.2    Elledge, R.3    Fuqua, S.A.4    Brown, R.W.5    Chamness, G.C.6    Osborne, C.K.7    McGuire, W.L.8
  • 22
    • 0028844391 scopus 로고
    • Hormonal regulation of the p53 tumor suppressor protein in T47D human breast carcinoma cell line
    • 10.1074/jbc.270.48.28507, 7499360
    • Hurd C, Khattree N, Alban P, Nag K, Jhanwar SC, Dinda S, Moudgil VK. Hormonal regulation of the p53 tumor suppressor protein in T47D human breast carcinoma cell line. J Biol Chem 1995, 270:28507-28510. 10.1074/jbc.270.48.28507, 7499360.
    • (1995) J Biol Chem , vol.270 , pp. 28507-28510
    • Hurd, C.1    Khattree, N.2    Alban, P.3    Nag, K.4    Jhanwar, S.C.5    Dinda, S.6    Moudgil, V.K.7
  • 24
    • 65949102326 scopus 로고    scopus 로고
    • Transcriptional regulation of estrogen receptor-alpha by p53 in human breast cancer cells
    • 10.1158/0008-5472.CAN-08-3628, 3079369, 19351845
    • Shirley SH, Rundhaug JE, Tian J, Cullinan-Ammann N, Lambertz I, Conti CJ, Fuchs-Young R. Transcriptional regulation of estrogen receptor-alpha by p53 in human breast cancer cells. Cancer Res 2009, 69:3405-3414. 10.1158/0008-5472.CAN-08-3628, 3079369, 19351845.
    • (2009) Cancer Res , vol.69 , pp. 3405-3414
    • Shirley, S.H.1    Rundhaug, J.E.2    Tian, J.3    Cullinan-Ammann, N.4    Lambertz, I.5    Conti, C.J.6    Fuchs-Young, R.7
  • 25
    • 0141988721 scopus 로고    scopus 로고
    • P53 function is required for hormone-mediated protection of mouse mammary tumorigenesis
    • Medina D, Kittrell FS. p53 function is required for hormone-mediated protection of mouse mammary tumorigenesis. Cancer Res 2003, 63:6140-6143.
    • (2003) Cancer Res , vol.63 , pp. 6140-6143
    • Medina, D.1    Kittrell, F.S.2
  • 26
    • 0035940463 scopus 로고    scopus 로고
    • P53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis
    • 10.1073/pnas.221459098, 60062, 11606748
    • Sivaraman L, Conneely OM, Medina D, O'Malley BW. p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis. Proc Natl Acad Sci USA 2001, 98:12379-12384. 10.1073/pnas.221459098, 60062, 11606748.
    • (2001) Proc Natl Acad Sci USA , vol.98 , pp. 12379-12384
    • Sivaraman, L.1    Conneely, O.M.2    Medina, D.3    O'Malley, B.W.4
  • 27
    • 20244370996 scopus 로고    scopus 로고
    • The tumor suppressor p53 is a negative regulator of estrogen receptor signaling pathways
    • 10.1006/bbrc.1997.7522, 9344880
    • Yu CL, Driggers P, Barrera-Hernandez G, Nunez SB, Segars JH, Cheng S. The tumor suppressor p53 is a negative regulator of estrogen receptor signaling pathways. Biochem Biophys Res Commun 1997, 239:617-620. 10.1006/bbrc.1997.7522, 9344880.
    • (1997) Biochem Biophys Res Commun , vol.239 , pp. 617-620
    • Yu, C.L.1    Driggers, P.2    Barrera-Hernandez, G.3    Nunez, S.B.4    Segars, J.H.5    Cheng, S.6
  • 28
    • 0034127791 scopus 로고    scopus 로고
    • Estrogen receptor protects p53 from deactivation by human double minute-2
    • Liu G, Schwartz JA, Brooks SC. Estrogen receptor protects p53 from deactivation by human double minute-2. Cancer Res 2000, 60:1810-1814.
    • (2000) Cancer Res , vol.60 , pp. 1810-1814
    • Liu, G.1    Schwartz, J.A.2    Brooks, S.C.3
  • 30
    • 76549137189 scopus 로고    scopus 로고
    • Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences
    • Menendez D, Inga A, Resnick MA. Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences. Proc Natl Acad Sci USA 107:1500-1505.
    • Proc Natl Acad Sci USA , vol.107 , pp. 1500-1505
    • Menendez, D.1    Inga, A.2    Resnick, M.A.3
  • 31
    • 0015550689 scopus 로고
    • Estrogen receptors in human breast cancer
    • 10.1172/JCI107175, 302228, 4345203
    • McGuire WL. Estrogen receptors in human breast cancer. J Clin Invest 1973, 52:73-77. 10.1172/JCI107175, 302228, 4345203.
    • (1973) J Clin Invest , vol.52 , pp. 73-77
    • McGuire, W.L.1
  • 32
    • 0025094132 scopus 로고
    • Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer
    • Reiner A, Neumeister B, Spona J, Reiner G, Schemper M, Jakesz R. Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer. Cancer Res 1990, 50:7057-7061.
    • (1990) Cancer Res , vol.50 , pp. 7057-7061
    • Reiner, A.1    Neumeister, B.2    Spona, J.3    Reiner, G.4    Schemper, M.5    Jakesz, R.6
  • 33
    • 0032896905 scopus 로고    scopus 로고
    • Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer
    • Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999, 17:1474-1481.
    • (1999) J Clin Oncol , vol.17 , pp. 1474-1481
    • Harvey, J.M.1    Clark, G.M.2    Osborne, C.K.3    Allred, D.C.4
  • 34
    • 0142216643 scopus 로고    scopus 로고
    • Prognosis in node-negative primary breast cancer: a neural network analysis of risk profiles using routinely assessed factors
    • 10.1093/annonc/mdg422, 14504047
    • Biganzoli E, Boracchi P, Coradini D, Grazia Daidone M, Marubini E. Prognosis in node-negative primary breast cancer: a neural network analysis of risk profiles using routinely assessed factors. Ann Oncol 2003, 14:1484-1493. 10.1093/annonc/mdg422, 14504047.
    • (2003) Ann Oncol , vol.14 , pp. 1484-1493
    • Biganzoli, E.1    Boracchi, P.2    Coradini, D.3    Grazia Daidone, M.4    Marubini, E.5
  • 35
    • 0034688187 scopus 로고    scopus 로고
    • Distinct prognostic values of p53 mutations and loss of estrogen receptor and their cumulative effect in primary breast cancers
    • 10.1002/(SICI)1097-0215(20000120)89:1<92::AID-IJC15>3.0.CO;2-8, 10719737
    • Takahashi M, Tonoki H, Tada M, Kashiwazaki H, Furuuchi K, Hamada J, Fujioka Y, Sato Y, Takahashi H, Todo S, Sakuragi N, Moriuchi T. Distinct prognostic values of p53 mutations and loss of estrogen receptor and their cumulative effect in primary breast cancers. Int J Cancer 2000, 89:92-99. 10.1002/(SICI)1097-0215(20000120)89:1<92::AID-IJC15>3.0.CO;2-8, 10719737.
    • (2000) Int J Cancer , vol.89 , pp. 92-99
    • Takahashi, M.1    Tonoki, H.2    Tada, M.3    Kashiwazaki, H.4    Furuuchi, K.5    Hamada, J.6    Fujioka, Y.7    Sato, Y.8    Takahashi, H.9    Todo, S.10    Sakuragi, N.11    Moriuchi, T.12
  • 40
    • 77951926837 scopus 로고    scopus 로고
    • Adverse prognostic value of vessel invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer
    • 2813305, 19633051, International Breast Cancer Study G
    • Viale G, Giobbie-Hurder A, Gusterson B, Maiorano E, Mastropasqua MG, Sonzogni A, Colleoni M, Castiglione-Gertsch M, Price KN, Gelber RD, Goldhirsch A, Coates AS, . International Breast Cancer Study G Adverse prognostic value of vessel invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer. Ann Oncol 2009, 21:245-254. 2813305, 19633051, International Breast Cancer Study G.
    • (2009) Ann Oncol , vol.21 , pp. 245-254
    • Viale, G.1    Giobbie-Hurder, A.2    Gusterson, B.3    Maiorano, E.4    Mastropasqua, M.G.5    Sonzogni, A.6    Colleoni, M.7    Castiglione-Gertsch, M.8    Price, K.N.9    Gelber, R.D.10    Goldhirsch, A.11    Coates, A.S.12
  • 42
    • 84857536692 scopus 로고    scopus 로고
    • Lost in translation? Estrogen receptor status and endocrine responsiveness in breast cancer
    • Harbeck N, Rody A. Lost in translation? Estrogen receptor status and endocrine responsiveness in breast cancer. J ClinOncol 2012, 30:686-689.
    • (2012) J ClinOncol , vol.30 , pp. 686-689
    • Harbeck, N.1    Rody, A.2
  • 46
    • 0029759541 scopus 로고    scopus 로고
    • Annual hazard rates of recurrence for breast cancer after primary therapy
    • Saphner T, Tormey DC, Gray R. Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol 1996, 14:2738-2746.
    • (1996) J Clin Oncol , vol.14 , pp. 2738-2746
    • Saphner, T.1    Tormey, D.C.2    Gray, R.3
  • 49
    • 77952848351 scopus 로고    scopus 로고
    • Deregulated estrogen receptor alpha and p53 heterozygosity collaborate in the development of mammary hyperplasia
    • 10.1158/0008-5472.CAN-09-3450, 2872114, 20466998
    • Diaz-Cruz ES, Furth PA. Deregulated estrogen receptor alpha and p53 heterozygosity collaborate in the development of mammary hyperplasia. Cancer Res 2010, 70:3965-3974. 10.1158/0008-5472.CAN-09-3450, 2872114, 20466998.
    • (2010) Cancer Res , vol.70 , pp. 3965-3974
    • Diaz-Cruz, E.S.1    Furth, P.A.2
  • 51
    • 67649832959 scopus 로고    scopus 로고
    • P53: structure, function and therapeutic applications
    • Bai L, Wei-Guo Z. p53: structure, function and therapeutic applications. Journal of Cancer Molecules 2006, 2:141-153.
    • (2006) Journal of Cancer Molecules , vol.2 , pp. 141-153
    • Bai, L.1    Wei-Guo, Z.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.